Gene · 3909
Papers1,589
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,589
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The aggressive behaviour of squamous cell carcinoma in epidermolysis bullosa: analysis of clinical outcomes and tumour characteristics in the Dutch EB Registry. | Br J Dermatol | 2022 | 35830206 | PubTator, text mining | PubMed |
| Spatially resolved proteomic map shows that extracellular matrix regulates epidermal growth. | Nat Commun | 2022 | 35817779 | PubTator, text mining | PubMed |
| The human amniotic epithelium confers a bias to differentiate toward the neuroectoderm lineage in human embryonic stem cells. | Elife | 2022 | 35815953 | PubTator, text mining | PubMed |
| Plac1 Remodels the Tumor Immune Evasion Microenvironment and Predicts Therapeutic Response in Head and Neck Squamous Cell Carcinoma. | Front Oncol | 2022 | 35814442 | PubTator, text mining | PubMed |
| Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF). | Cells | 2022 | 35805179 | PubTator, text mining | PubMed |
| The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities. | Cancers (Basel) | 2022 | 35805064 | PubTator, text mining | PubMed |
| Characterization of core fucosylation via sequential enzymatic treatments of intact glycopeptides and mass spectrometry analysis. | Nat Commun | 2022 | 35798744 | PubTator, text mining | PubMed |
| Regionally distinct trophoblast regulate barrier function and invasion in the human placenta. | Elife | 2022 | 35796428 | PubTator, text mining | PubMed |
| BUB1 Is Identified as a Potential Therapeutic Target for Pancreatic Cancer Treatment. | Front Public Health | 2022 | 35769782 | PubTator, text mining | PubMed |
| The dynamic roles of the bladder tumour microenvironment. | Nat Rev Urol | 2022 | 35764795 | PubTator, text mining | PubMed |
| Targeted Proteins Reveal Cathepsin D as a Novel Biomarker in Differentiating Hepatocellular Carcinoma from Cirrhosis and Other Liver Cancers | Asian Pac J Cancer Prev | 2022 | 35763644 | PubTator, text mining | PubMed |
| Tracking the Molecular Scenarios for Tumorigenic Remodeling of Extracellular Matrix Based on Gene Expression Profiling in Equine Skin Neoplasia Models. | Int J Mol Sci | 2022 | 35742950 | PubTator, text mining | PubMed |
| Comprehensive Integrated Single-Cell Whole Transcriptome Analysis Revealed the p-EMT Tumor Cells-CAFs Communication in Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2022 | 35742914 | PubTator, text mining | PubMed |
| Epidermolysis Bullosa-A Different Genetic Approach in Correlation with Genetic Heterogeneity. | Diagnostics (Basel) | 2022 | 35741135 | PubTator, text mining | PubMed |
| Multi-Omics Reveal Additive Cytotoxicity Effects of Aflatoxin B1 and Aflatoxin M1 toward Intestinal NCM460 Cells. | Toxins (Basel) | 2022 | 35737029 | PubTator, text mining | PubMed |
| Simplexviruses Successfully Adapt to Their Host by Fine-Tuning Immune Responses. | Mol Biol Evol | 2022 | 35731846 | PubTator, text mining | PubMed |
| PCOS and Role of Cumulus Gene Expression in Assessing Oocytes Quality. | Front Endocrinol (Lausanne) | 2022 | 35721714 | PubTator, text mining | PubMed |
| Isolated steroid-resistant nephrotic syndrome in a Chinese child carrying a de novo mutation in WT1 gene:a case report and literature review. | BMC Pediatr | 2022 | 35710404 | PubTator, text mining | PubMed |
| Combined analyses of RNA-sequence and Hi-C along with GWAS loci-A novel approach to dissect keloid disorder genetic mechanism. | PLoS Genet | 2022 | 35709140 | PubTator, text mining | PubMed |
| Vitamin C stimulates RNA expression of human gingival fibroblasts proliferation and adhesion in cigarette smokers: An in vitro study. | Saudi Dent J | 2022 | 35692237 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3909/papers?page=18